AAAAAA

   
Results: 1-9 |
Results: 9
Coscinosulfate, a CDC25 phosphatase inhibitor from the sponge Coscinodermamathewsi
Authors: Loukaci, A Le Saout, I Samadi, M Leclerc, S Damiens, E Meijer, L Debitus, C Guyot, M
Citation: A. Loukaci et al., Coscinosulfate, a CDC25 phosphatase inhibitor from the sponge Coscinodermamathewsi, BIO MED CH, 9(11), 2001, pp. 3049-3054
Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest
Authors: Damiens, E Baratte, B Marie, D Eisenbrand, G Meijer, L
Citation: E. Damiens et al., Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest, ONCOGENE, 20(29), 2001, pp. 3786-3797
Prevention of chemotherapy-induced alopecia by cyclin-dependant kinase inhibitors
Authors: Meijer, L Knockaert, M Damiens, E
Citation: L. Meijer et al., Prevention of chemotherapy-induced alopecia by cyclin-dependant kinase inhibitors, B CANCER, 88(4), 2001, pp. 347-350
Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors
Authors: Knockaert, M Gray, N Damiens, E Chang, YT Grellier, P Grant, K Fergusson, D Mottram, J Soete, M Dubremetz, JF Le Roch, K Doerig, C Schultz, PG Meijer, L
Citation: M. Knockaert et al., Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors, CHEM BIOL, 7(6), 2000, pp. 411-422
Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line
Authors: Dhennin-Duthille, I Masson, M Damiens, E Fillebeen, C Spik, G Mazurier, J
Citation: I. Dhennin-duthille et al., Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line, J CELL BIOC, 79(4), 2000, pp. 583-593
Chemical inhibitors of cyclin-dependent kinases: preclinical and clinical studies.
Authors: Damiens, E Meijer, L
Citation: E. Damiens et L. Meijer, Chemical inhibitors of cyclin-dependent kinases: preclinical and clinical studies., PATH BIOL, 48(3), 2000, pp. 340-351
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases
Authors: Hoessel, R Leclerc, S Endicott, JA Nobel, MEM Lawrie, A Tunnah, P Leost, M Damiens, E Marie, D Marko, D Niederberger, E Tang, WC Eisenbrand, G Meijer, L
Citation: R. Hoessel et al., Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases, NAT CELL BI, 1(1), 1999, pp. 60-67
Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells
Authors: Damiens, E El Yazidi, I Mazurier, J Duthille, I Spik, G Boilly-Marer, Y
Citation: E. Damiens et al., Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells, J CELL BIOC, 74(3), 1999, pp. 486-498
Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line
Authors: Damiens, E El Yazidi, I Mazurier, J Elass-Rochard, E Duthille, I Spik, G Boilly-Marer, Y
Citation: E. Damiens et al., Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line, EUR J CELL, 77(4), 1998, pp. 344-351
Risultati: 1-9 |